The Melanoma Market and Implications of Key Data From SITC 2023
Date Aired : Wednesday, November 15, 2023
Duration: 60 minutes The 2023 Society for Immunotherapy of Cancer (SITC) annual conference will feature some key catalysts for the melanoma market. Join Bloomberg Intelligence analysts Max Nisen and Tish Walker as they discuss the latest development in the melanoma market, including the rise of neoadjuvant therapy as a potential new standard of care. We'll also discuss the potential size of that market and the upcoming patent cliff for melanoma mainstays like Opdivo and Keytruda and the possibility for the Inflation Reduction Act to cut prices first.
Duration: 60 minutes The 2023 Society for Immunotherapy of Cancer (SITC) annual conference will feature some key catalysts for the melanoma market. Join Bloomberg Intelligence analysts Max Nisen and Tish Walker as they discuss the latest development in the melanoma market, including the rise of neoadjuvant therapy as a potential new standard of care. We'll also discuss the potential size of that market and the upcoming patent cliff for melanoma mainstays like Opdivo and Keytruda and the possibility for the Inflation Reduction Act to cut prices first.